The Novel Allele, HLA‐B*58:01:46 , Was Identified in a Chinese Individual by Next‐Generation Sequencing
HLA · 2025
DOI: 10.1111/tan.70451 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Xin Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Laboratory, Henan Red Cross Blood Center, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, HLA-B Antigens, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
The novel allele HLA‐B*58:01:46 differs from HLA‐B*58:01:01:03 by a single nucleotide substitution in codon 49 GCG → GCC in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Laboratory, Henan Red Cross Blood Center, Zhengzhou, Henan, China.
- Henan Blood Safety Research Institute, Zhengzhou, Henan, China.
Zitieren
APA
Peng, X., Wang, Z., Sun, Y., Kang, Y., & Liu, Z. (2025). The Novel Allele, HLA‐B*58:01:46 , Was Identified in a Chinese Individual by Next‐Generation Sequencing. HLA. https://doi.org/10.1111/tan.70451
Vancouver
Peng X, Wang Z, Sun Y, Kang Y, Liu Z. The Novel Allele, HLA‐B*58:01:46 , Was Identified in a Chinese Individual by Next‐Generation Sequencing. HLA. 2025. doi:10.1111/tan.70451
BibTeX
@article{Peng2025,
author = {Peng, Xin and Wang, Ziqing and Sun, Yamin and Kang, Yiqing and Liu, Zheng},
title = {The Novel Allele, HLA‐B*58:01:46 , Was Identified in a Chinese Individual by Next‐Generation Sequencing},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70451}
}
EUVIMED